產(chǎn)品詳情
簡單介紹：
Anti-C9orf103抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C9orf103抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C9orf103
Cat. Number:
Anti-C9orf103抗體KL-15308R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C9orf103 (chromosome 9 open reading frame 103), also known as gluconate kinase, is a 187 amino acid protein that belongs Anti-C9orf103抗體to the gluconokinase gntK/gntV family and catalyzes the conversion of ATP and D-gluconate to ADP and 6-phospho-D-gluconate. Existing as three alternatively spliced isoforms, the gene encoding C9orf103 maps to human chromosome 9q21.32. Chromosome 9 consists of about 145 million bases, represents 4% of the human genome and encodes nearly 900 genes. Thought to play a role in gender determination, deletion of the distal portion of 9p can lead to development of male to female sex reversal, the phenotype of a female with a male X,Y genotype. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects, is associated with the chromosome 9 gene encoding endoglin protein, ENG. Familial dysautonomia is also associated with chromosome 9 though through the gene IKBKAP. Notably, chromosome 9 encompasses the largest interferon family gene cluster.
Also known as:
bA522I20.2; C9orf103; Anti-C9orf103抗體Chromosome 9 open reading frame 103; Glucokinase like protein; Gluconate kinase; Gluconokinase like protein; GNTK_HUMAN; IDNK; OTTHUMP00000021546; OTTHUMP00000021547; Probable gluconokinase; RP11-522I20.2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C9orf103.
●
Predicted Molecular Weight: 21kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C9orf103抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-C9orf103抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-C9orf103抗體 must be determined by the end user.
kl309Mu01 糜蛋白酶樣蛋白(CTRL)多克隆抗體 Polyclonal Antibody to Chymotrypsin Like Protein (CTRL)
kl309Ra01 糜蛋白酶樣蛋白(CTRL)多克隆抗體 Polyclonal Antibody to Chymotrypsin Like Protein (CTRL)
kl178Hu01 胰輔脂酶(CLPS)多克隆抗體 Polyclonal Antibody to Colikle, klcreatic (CLPS)
kl178Mu01 胰輔脂酶(CLPS)多克隆抗體 Polyclonal Antibody to Colikle, klcreatic (CLPS)
kl178Ra01 胰輔脂酶(CLPS)多克隆抗體 Polyclonal Antibody to Colikle, klcreatic (CLPS)
kl178Po01 胰輔脂酶(CLPS)多克隆抗體 Polyclonal Antibody to Colikle, klcreatic (CLPS)
kl835Hu01 促腎上皮質(zhì)**釋放**(CRH)多克隆抗體 Polyclonal Antibody to Corticotropin Releasing Hormone (CRH)
kl835Mu01 促腎上皮質(zhì)**釋放**(CRH)多克隆抗體 Polyclonal Antibody to Corticotropin Releasing Hormone (CRH)
kl835Ra01 促腎上皮質(zhì)**釋放**(CRH)多克隆抗體 Polyclonal Antibody to Corticotropin Releasing Hormone (CRH)
kl540Ge01 皮質(zhì)酮(Cort)多克隆抗體 Polyclonal Antibody to Corticosterone (Cort)
kl821Gu01 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl821Rb52 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl821Po01 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl821Bo01 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl821Ga01 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl821Fi01 C反應(yīng)蛋白(CRP)多克隆抗體 Polyclonal Antibody to C Reactive Protein (CRP)
kl089Ge01 脫氧膽酸(DC)多克隆抗體 Polyclonal Antibody to Deoxycholate (DC)
